PMC:7346000 / 12586-12887
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T36 | 47-51 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
| T37 | 274-278 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T6 | 47-51 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
| T7 | 274-278 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 364 | 47-58 | Disease | denotes | lung damage | MESH:D008171 |
| 365 | 80-88 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 366 | 136-140 | Disease | denotes | ARDS | MESH:D012128 |
| 367 | 274-286 | Disease | denotes | lung defects | MESH:D008171 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T130 | 80-88 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T131 | 136-140 | Disease | denotes | ARDS | http://purl.obolibrary.org/obo/MONDO_0006502 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T85 | 47-51 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
| T86 | 47-51 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
| T87 | 90-92 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
| T88 | 274-278 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
| T89 | 274-278 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T74 | 106-121 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
| T75 | 179-190 | Chemical | denotes | antibiotics | http://purl.obolibrary.org/obo/CHEBI_33281 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T66 | 0-301 | Sentence | denotes | The most important risk factors include severe lung damage during the course of COVID-19 [48], the use of corticosteroids in those with ARDS, the widespread use of broad-spectrum antibiotics in intensive care units [49], and the presence of comorbidities such as structural lung defects [47,50,51,52]. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32599813-32043983-60095107 | 90-92 | 32043983 | denotes | 48 |
| 32599813-32339350-60095108 | 291-293 | 32339350 | denotes | 50 |
| 32599813-32488446-60095109 | 297-299 | 32488446 | denotes | 52 |